Hearing Loss in Tuberculosis Relapse Patient with Streptomycin Treatment : A Case Report Fiya Natilda (a) Yanti Nurrokhmawati (b) P.W. Prastianingsih (a) Judiawati Hayat (a)
a. Otorhinolaryngology-Head and Neck Surgery Department at Cibabat General Hospital, Cimahi, West Java, Indonesia
b. Otorhinolaryngology-Head and Neck Surgery Department at Dustira Hospital, Cimahi, West Java, Indonesia
Abstract
There are lots of possible causes of hearing loss and ototoxicity is an increasing cause of hearing loss in developing countries. Aminoglycoside antibiotics are the most common cause of ototoxic. Streptomycin belongs to the class of amynoglycosides, which is widely used as a part of treatment for relapse tuberculosis patient. Streptomycin is known to cause hearing loss. a study case of a 51-year-old man was referred to our otorhinolaryngology Department at cibabat general hospital with a month history of sudden bilateral hearing loss after 56 days of streptomycin treatment. The patient claimed that it was hard for him to walk and maintaining straight posture a week after first treatment and he had blurry vision three weeks after his first streptomycin treatment. Patient treated with ATT therapy (CAT IInd) which is included a daily dose of streptomycin (750mg) for 56 days. Pure Tone Audiometry showed bilateral sensorineural hearing loss. The patient is under observation after the discontinuation of streptomycin. Hearing rehabilitation with hearing aids will be considered if required. Untreated hearing loss and delayed treatment can leads to further damage and known to cause permanent hearing loss. Nowadays, early diagnosed of otoxicity related to the treatment of relaps tuberculosis remains a challenge. Therefore early detection and proper treatments of hearing loss are crucial to prevent the damage and lower the individual^s quality of life.
